Ten years after MIDAS: Icodextrin lights and shadows

Contributions to Nephrology

Volumn 140, Issue , 2003, Pages 76-81

  Amici, Gianpaolo ^a   Da Rin, Giorgio ^a   Agostini, Adriano ^a   Velo, Sonia ^a   Bocci, Carlo ^a  

^a OSPEDALE CA FONCELLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1942501498     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000071426     Document Type: Article

References (29)

1. Mistry CD, Gokal R, Peers E: A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solution in CAPD. MIDAS Study Group. Kidney Int 1994;46:496-503.
2. Mistry CD: Glucose polymer as an osmotic agent in continuous ambulatory peritoneal dialysis; MD thesis, University of London, 1988.
3. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, Donker JM: Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-hour dialysate creatinine clearance. Nephrol Dial Transplant 1997;12:550-553.
4. Plum J, Gentile S, Verger C, Brunkhorst R, Banner U, Faller B, et al: Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002;39:862-871.
5. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM: Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 1999;14:1530-1535.
6. Cancarini G: Strategy for preventing peritoneal dialysis failure. Contrib Nephrol. Basel, Karger, 2001, vol 131, pp 114-124.
7. Krediet RT, van Hestrhenen R, Zweers MM, Struijk DG: Clinical advantages of new peritoneal dialysis solutions. Nephrol Dial Transplant 2002;17(suppl 3):16-18.
8. Posthuma N, ter Wee PM, Donker JM, Peers EM, Oe PL, Verbrugh HA: Icodextrin use in CCPD patients during peritonitis: Ultrafiltration and serum disaccharide concentrations. Nephrol Dial Transplant 1998;13:2341-2344.
9. Amici G, Bocci C, Orrasch M, Da Rin G, Calconi G: Hyperinsulinism reduction associated with icodextrin treatment in CAPD patients. Adv Perit Dial 2001;17:80-83.
10. Wolfson M, Ogrinc F, Mujais S: Review of clinical experience with icodextrin. Kidney Int 2002;62(suppl 81):46-52.
11. Wang R, Moberly JB, Martis L, Shockley TR, Mongoven JW, Patel H, et al: A rapid assay for icodextrin determination in plasma and dialysate. Adv Perit Dial 2002;18:91-95.
12. Amici G, Da Rin G, Verrina E, Carrea A, Perfumo F, Garcia-Lopez E, et al: Total icodextrin assay in dialysate and plasma by enzymatic acid-warm hydrolysis. Perit Dial Int 2002;22:118.
13. Amici G, Bocci C: Icodextrin absorption and ultrafiltration curve over 16h dwell time. Perit Dial Int 2000;20:104.
14. Thodis E, Passadakis P, Panagoutsos S, Marinopoulos D, Vargemezi V: Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 1999;15:171-174.
15. 125I-radioiodinated serum albumin in peritoneal dialysis with icodextrin. Perit Dial Int 2002;22:131.
16. Amici G, Da Rin G, Puggia R, Virgilio B, Zagatti R, Bocci C: Icodextrin dialytic and plasmatic metabolites in an extra-long peritoneal dialysis dwell. J Nephrol 2002;15:731.
17. Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, et al : Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int 2002;62(suppl 81):23-33.
18. Goldsmith D, Jayawardene S, Sabharwal N, Cooney S: Allergic reactions to the polymeric glucose-based peritoneal dialysis fluid icodextrin in patients with renal failure. Lancet 2000;355:897.
19. Divino Filho JC: Allergic reactions to icodextrin in patients with renal failure. Lancet 2000;355:1364-1365.
20. Montagnac R, Slingeneyer A, Schillinger F: Aseptic peritonitis: Role of icodextrin. Nephrol Dial Transplant 2001;16:435-436.
21. Williams PF, Foggensteiner L: Sterile/allergic peritonitis with icodextrin in CAPD patients. Perit Dial Int 2002;22:89-90.
22. MacGinley R, Cooney K, Alexander G, Cohen S, Goldsmith DJ: Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution. Am J Kidney Dis 2002;40:1030-1035.
23. Pinerolo MC, Porri MT, D'Amico G: Recurrent sterile peritonitis at onset of treatment with icodextrin solution. Perit Dial Int 1999;19:491-492.
24. Cooker LA, Holmes CJ, Hoff CM: Biocompatibility of icodextrin. Kidney Int 2002;62(suppl 81):34-45.
25. Garcia-Lopez E, Lindholm B, Tranaeus A: Biocompatibility of new peritoneal dialysis solutions: Clinical experience. Perit Dial Int 2000;20(suppl 5):48-56.
26. Bajo MA, Selgas R, Castro MA, del Peso G, Diaz C, Sanchez-Tomero JA, et al: Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo. Perit Dial Int 2000;20:742-747.
27. Gotloib L, Wajsbrot V, Shostak A: Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin. Nephron 2002;92:142-155.
28. Frajewicki V, Kushnir D, Wajsbrot V, Kohan R, Shostak A, Gotloib L: Peritoneal transport after long-term exposure to icodextrin in rats. Nephron 2002;92:174-182.
29. Ho-dac-Pannekeet MM, Weiss MF, de Waart DR, Erhard P, Hiralall JK, Krediet RT: Analysis of non-enzymatic glycosylation in vivo: Impact of different dialysis solutions. Perit Dial Int 1999;19(suppl 2):68-74.